Article Details

FDA after Gottlieb: Sharpless expected to push predecessor's agenda during transition

Retrieved on: 2019-05-22 03:41:15

Tags for this article:

Click the tags to see associated articles and topics

FDA after Gottlieb: Sharpless expected to push predecessor's agenda during transition. View article details on hiswai:

Excerpt

<div>As reported by Axios today, Gottlieb was returning to the venture capital firm <b>New</b> <b>Enterprise Associates</b> as a full-time investing partner, with a focus on ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up